sulfadimethoxine sulfadimethoxine sulfadimethoxine (or sulphadimethoxine, trade names di-methox or albon) is a long-lasting sulfonamide antimicrobial medication used in veterinary medicine. it is used to treat many infections, including respiratory, urinary tract, enteric, and soft tissue infections and can be given as a standalone or combined with ormetoprim to broaden the target range. like all sulfamides, sulfadimethoxine inhibits bacterial synthesis of folic acid by acting as a competitive inhibitor against paba. it is the most common drug prescribed to dogs who have coccidiosis. sulfadimethoxineclinical datatrade namesalbon, di-methoxahfs/drugs.comfda professional drug informationroutes ofadministrationby mouth; can be iv in cattleatc codej01ed02 (who) qj01eq09 (who) qp51ag02 (who)legal statuslegal status au: s4 (prescription only) us: ℞-only (by veterinarian) pharmacokinetic databioavailability55–60%elimination half-life13.1 hours in dogsidentifiers iupac name 4-amino-n-(2,6-dimethoxypyrimidin-4-yl)benzenesulfonamide cas number122-11-2 ypubchem cid5323drugbankdb06150 ychemspider5132 yunii30cpc5ldexkeggd01142 ychebichebi:32161 ychemblchembl62193 ycomptox dashboard (epa)dtxsid1023607 echa infocard100.004.113 chemical and physical dataformulac12h14n4o4smolar mass310.33 g·mol−13d model (jsmol)interactive image smiles coc1cc(nc(n1)oc)ns(=o)(=o)c2ccc(cc2)n inchi inchi=1s/c12h14n4o4s/c1-19-11-7-10(14-12(15-11)20-2)16-21(17,18)9-5-3-8(13)4-6-9/h3-7h,13h2,1-2h3,(h,14,15,16) ykey:zzorfufydownef-uhfffaoysa-n y (verify) mechanism like other sulfonamides, sulfadimethoxine is a dihydropteroate synthase inhibitor. bacteria and some protozoa are unable to obtain folic acid from the environment, and must instead synthesize it by converting paba (para-aminobenzoate) to dihydropteroate using the enzyme dihydropteroate synthase. sulfonamides act as a competitive inhibitor; being structurally similar to paba, they are able to bind to the enzyme's active site and prevent the synthesis of folic acid from progressing. folic acid is necessary for these organisms to produce nucleic acids (i.e. dna and rna), which are required for cell division. thus, it has a microbiostatic effect rather than a microbiocidal one (it prevents pathogen growth rather than killing them), and has the strongest effect in the beginning stages of an infection, when the pathogen is rapidly dividing. since it is microbiostatic, sulfadimethoxine still requires the animal to still be able to mount an immune response to kill the pathogen. with ormetoprim sulfadimethoxine can either be given alone (such as under the commercial name albon) or in combination with ormetoprim to as a "potentiated sulfonamide" to increase antimicrobial activity. ormetoprim is a diaminopyridine, inhibiting dihydrofolate reductase, which is further along the pathway for synthesizing folic acid. though the optimum ratio of sulfadimethoxine to ormetoprim has been found to be 20:1, it is sold pharmaceutically as a 5:1 mixture. pharmacokinetics suspension and bottle of pills of sulfadimethoxine, sold under the trade name albon. sulfadimethoxine, like all sulfonamides, diffuses easily when it is in its unionized, lipid-soluble form, and easily reaches many tissues. the relative amounts are determined by both its pka and by the ph of each tissue. therefore, levels tend to be higher in less acidic tissue and body fluids or in diseased tissues having high concentrations of leucocytes. its ability to bind to plasma proteins is very high, leading sulfadimethoxine to maintain higher blood levels than most other long-acting sulfonamides. comparatively low doses can give rapid and sustained therapeutic blood levels. most animals for which sulfadimethoxine is marketed acetylate sulfadimethoxine in the liver to form acetylsulfadimethoxine, which is secreted in the bile. dogs are the exception – since they are unable acetylate sulfonamides, they excrete sulfadimethoxine mostly unchanged in the urine (their inability to transform sulfadimethoxine also makes them more susceptible to negative side effects). sulfadimethoxine has a relatively high solubility at the ph normally occurring in the kidneys, and is easily reabsorbed into the renal tubules, adding to its long half-life. the use of sulfadimethoxine raises concerns that it will precipitate in the kidneys, leading to crystalluria. though crystallization is not actually a common occurrence in veterinary medicine, it can be avoided entirely by adding a diaminopyrimidine such as ormetoprim. having the animal stay well-hydrated also is advised. usage sulfadimethoxine is the only fda-approved drug for treating intestinal coccidioisis in cats and dogs. it is also used for: treating skin and soft-tissue infections in dogs caused by staphylococcus aureus or e. coli treating cattle for bovine respiratory disease complex ("shipping fever complex"), necrotic pododermatitis (foot rot), pneumonia when caused by pasteurella, and calf diphtheria caused by fusobacterium necrophorum when combined with ormetoprim: treating soft tissue infections, skin infections, urinary tract infections, and intestinal coccidia infections in dogs prevention of fowl cholera and coccidioisis by eimeria in poultry treating salmon and trout for furunculosis it is also one of the only sulfonamides allowed for treating lactating dairy cattle (the others being sulfabromethazine and sulfathoxypyridazine). notes "sulfamed (sulfadimethoxine) injection 40% for animal use". drugs.com. retrieved 2017-06-18. riviere je, papich mg (2013-05-13). veterinary pharmacology and therapeutics. john wiley & sons. pp. 836, 845, 857, 1169. isbn 9781118685907. "albon – sulfadimethoxine suspension". dailymed. us national library of medicine. 2014-05-21. retrieved 2017-06-17. ward e (2008-12-08). "coccidiosis in dogs". know your pet. vca hospitals. retrieved 2017-06-18. bauman rw (2015). microbiology: with diseases by body system (4th ed.). boston: pearson. p. 296. isbn 9780321918550. "sulfonamides and sulfonamide combinations". merck veterinary manual. retrieved 2017-06-18. stowe cm (1965). "chapter 33: the sulfonamides". in jones lm (ed.). veterinary pharmacology and therapeutics. ames, iowa: iowa state university press. plumb dc (2011). plumb's veterinary drug handbook (7th ed.). ames, iowa: wiley. pp. 951, 954. isbn 9780470959640. papich mg (2007). saunders handbook of veterinary drugs (2nd ed.). st. louis, mo: saunders/elsevier. isbn 9781416028888. bridges jw, kibby mr, walker sr, williams rt (october 1968). "species differences in the metabolism of sulphadimethoxine". the biochemical journal. 109 (5): 851–6. doi:10.1042/bj1090851. pmc 1187037. pmid 4972257. baggot jd (march 1970). "some aspects of drug persistence in domestic animals". research in veterinary science. 11 (2): 130–7. doi:10.1016/s0034-5288(18)34350-9. pmid 5499300. petcoach editorial team. "sulfadimethoxine (albon)". petcoach. this article incorporates text from the united states national library of medicine (albon sulfadimethoxine suspension), which is in the public domain. antibacterials that inhibit nucleic acid (j01e, j01m)antifolates(inhibit bacterialpurine metabolism,thereby inhibitingdna and rnasynthesis)dhfr inhibitor 2,4-diaminopyrimidine brodimoprim iclaprim† ormetoprim pyrimethamine# tetroxoprim trimethoprim# sulfonamides(dhps inhibitor)short-acting sulfaisodimidine sulfamethizole sulfadimidine sulfapyridine (sulfasalazine) sulfafurazole (acetyl sulfisoxazole) sulfanilamide prontosil sulfathiazole (phthalylsulfathiazole, succinylsulfathiazole) sulfathiourea intermediate-acting sulfamethoxazole sulfadiazine# sulfamoxole long-acting sulfadimethoxine sulfadoxine sulfalene sulfametomidine sulfametoxydiazine sulfamethoxypyridazine sulfaperin sulfamerazine sulfaphenazole sulfamazone other/ungrouped mafenide sulfacetamide sulfaclozine sulfadicramide sulfaguanidine sulfametrole sulfanitran combinations trimethoprim/sulfamethoxazole# ormetoprim/sulfadimethoxine pyrimethamine/dapsone pyrimethamine/sulfadoxine other dhps inhibitors acediasulfone dapsone solasulfone sulfoxone quinolones(inhibit bacterialtopoisomeraseand/or dna gyrase,thereby inhibitingdna replication)1st generation cinoxacin‡ flumequine‡ nalidixic acid‡ oxolinic acid‡ pipemidic acid‡ piromidic acid‡ rosoxacin‡ fluoroquinolones2nd generation ciprofloxacin# ofloxacin enoxacin‡ fleroxacin‡ lomefloxacin‡ nadifloxacin‡ norfloxacin‡ pefloxacin‡ rufloxacin‡ 3rd generation levofloxacin# balofloxacin‡ grepafloxacin‡ pazufloxacin‡ sparfloxacin‡ temafloxacin‡ tosufloxacin‡ 4th generation besifloxacin delafloxacin gatifloxacin finafloxacin gemifloxacin moxifloxacin# clinafloxacin† garenoxacin‡ prulifloxacin‡ sitafloxacin‡ trovafloxacin‡/alatrofloxacin‡ veterinary danofloxacin difloxacin enrofloxacin ibafloxacin marbofloxacin orbifloxacin pradofloxacin sarafloxacin‡ newer non-fluorinated nemonoxacin ozenoxacin related (dg) aminocoumarins: novobiocin anaerobic dnainhibitorsnitroimidazole derivatives metronidazole# ornidazole secnidazole tinidazole nitrofuran derivatives furazolidone‡ nifuroxazide nifurtoinol nifurzide nitrofurantoin# nitrofurazone rna synthesisrifamycins/rna polymerase rifampicin# rifabutin# rifapentine# rifaximin rifalazil§ lipiarmycins fidaxomicin #who-em ‡withdrawn from market clinical trials: †phase iii §never to phase iii this article is issued from wikipedia. the text is licensed under creative commons - attribution - sharealike. additional terms may apply for the media files.